The new policy prohibits federal funds from covering gender-affirming care for children enrolled in Medicaid or the Children's Health Insurance Program.

The Trump administration has finalized a health care policy that bans the use of federal dollars for gender-affirming care for children covered by Medicaid or the Children's Health Insurance Plan (CHIP). The rule, which was proposed in December, was issued at the direction of President Trump. Officials cited concerns over the evidence supporting such procedures and alleged fraudulent billing practices by providers as the basis for the decision.

Impact on Families and Providers

The policy affects an estimated 130,000 transgender youth living in states where such care remains available. For families like that of A.W., a parent of a transgender teenager who relies on Medicaid, the rule creates significant uncertainty regarding continued access to medical services. Some states have vowed to challenge the rule in court or provide state-level funding to backfill the lost federal support, though experts note this may cause significant administrative disruption.

Broader Administration Actions

Alongside the formal policy change, the administration released a report and a documentary titled "Wolves in White Coats," which allege that doctors and hospitals are driven by financial gain in providing gender-affirming care. The administration has also referred dozens of health care providers to the Department of Health and Human Services inspector general and the Justice Department for investigations into potential billing fraud. Experts suggest these actions are intended to create fear within the provider community, leading some hospitals to roll back gender-affirming programs.